| 000 | 01568 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516203848.0 | ||
| 264 | 0 | _c20160108 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1433-8726 | ||
| 024 | 7 |
_a10.1007/s00345-014-1281-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOh, Daniel S | |
| 245 | 0 | 0 |
_aStatin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy. _h[electronic resource] |
| 260 |
_bWorld journal of urology _cJan 2015 |
||
| 300 |
_a93-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmortality |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBrachytherapy |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aProstate-Specific Antigen |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKoontz, Bridget | |
| 700 | 1 | _aFreedland, Stephen J | |
| 700 | 1 | _aGerber, Leah | |
| 700 | 1 | _aPatel, Pretesh | |
| 700 | 1 | _aLewis, Stephen | |
| 700 | 1 | _aYoo, David S | |
| 700 | 1 | _aOleson, James | |
| 700 | 1 | _aSalama, Joseph K | |
| 773 | 0 |
_tWorld journal of urology _gvol. 33 _gno. 1 _gp. 93-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00345-014-1281-x _zAvailable from publisher's website |
| 999 |
_c23679328 _d23679328 |
||